Beam Therapeutics
BEAM
BEAM
220 hedge funds and large institutions have $1.94B invested in Beam Therapeutics in 2024 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 75 increasing their positions, 66 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% more capital invested
Capital invested by funds: $1.82B → $1.94B (+$117M)
3% more funds holding
Funds holding: 213 → 220 (+7)
1.63% more ownership
Funds ownership: 94.27% → 95.9% (+1.6%)
Holders
220
Holding in Top 10
3
Calls
$12.1M
Puts
$6.22M
Top Buyers
| 1 | +$32.5M | |
| 2 | +$32.5M | |
| 3 | +$31.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$17.8M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$12.3M |
Top Sellers
| 1 | -$35.9M | |
| 2 | -$26.8M | |
| 3 | -$20M | |
| 4 |
AVM
Arch Venture Management
Chicago,
Illinois
|
-$14.9M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$9.61M |